What is the primary driver of CME Group's revenue growth in this period?

CME Group's revenue growth is primarily driven by an increase in clearing and transaction fees. This growth is supported by a higher average rate per contract, which is influenced by fee adjustments and changes in the product mix, as well as stable overall contract volumes. Additionally, market data and information services revenue also contributed positively to the overall revenue growth.

How has the performance of interest rate and equity index products contributed to the results?

Interest rate products have shown strong performance, with increased contract volumes and average rates per contract, driven by higher interest rate volatility and the transition from LIBOR to SOFR. Equity index product volumes have decreased compared to the prior year, attributed to lower equity market volatility. Despite the dip in equity index volumes, the overall revenue growth was sustained by the strong performance in interest rate products and other segments.

What are the key factors contributing to the increase in operating expenses?

The increase in operating expenses is mainly attributable to higher compensation and benefits, reflecting increased headcount and non-qualified deferred compensation adjustments. Additionally, higher technology support services expenses related to the Google Cloud transformation project and employee separation costs due to restructuring initiatives also contributed to the rise in expenses. However, the company has managed these increases effectively relative to revenue growth, maintaining a strong operating margin.

What is CME Group's outlook regarding its financial health and liquidity?

CME Group maintains a strong financial position with healthy operating cash flows and substantial liquidity. The company has significant availability under its revolving credit facilities and a substantial amount of cash and cash equivalents. Management expects to maintain an investment-grade credit rating, supported by its consistent cash flow generation and ability to manage debt levels. The company is also compliant with all regulatory requirements for its clearing and trading operations.

CME 10-Q Quarterly Report Q3 FY2023 — Revenue, Net Income, EPS

Summary

CME Group Inc. reported strong financial performance for the third quarter and first nine months of 2023, demonstrating robust revenue growth and increased profitability. Total revenues rose by 9% year-over-year to $1.34 billion for the quarter and by 9% to $4.14 billion for the nine-month period, driven primarily by a significant increase in clearing and transaction fees. This growth was fueled by a 10% increase in revenue from interest rate products, reflecting higher market volatility, and a 12% rise in the average rate per contract due to fee adjustments and product mix. Net income saw a substantial increase of 10% to $750.2 million for the quarter and a notable 17% for the nine-month period, reaching $2.41 billion. This profitability improvement, coupled with effective cost management, resulted in diluted earnings per share (EPS) of $2.06 for the quarter and $6.62 for the nine months. The company maintains a strong financial position, with healthy operating cash flows and substantial liquidity, supported by its diverse revenue streams and robust clearing operations.

Financial Highlights

45 data points

Beta

Revenue

$1.34B

Net Income

$750.20M

0.6% Net Margin

EPS (Diluted)

$2.06

Total Assets

$125.60B

Cash & Equivalents

$2.30B

Free Cash Flow

$836.80M

Financial Statements

Beta

Revenue	$1.34B
Operating Expenses	$517.60M
Operating Income	$820.20M
Net Income	$750.20M
EPS (Basic)	$2.06
EPS (Diluted)	$2.06
Shares Outstanding (Basic)	359.02M
Shares Outstanding (Diluted)	359.62M

Key Highlights

1Total revenues increased by 9% to $1.34 billion for the third quarter and by 9% to $4.14 billion for the first nine months of 2023, compared to the prior year periods.
2Clearing and transaction fees, the company's largest revenue segment, grew by 9% for the quarter and 8% for the nine months, driven by an increase in average rate per contract and stable overall contract volume.
3Net income rose by 10% to $750.2 million for the quarter and by 17% to $2.41 billion for the nine months, indicating strong operational efficiency and profitability.
4Diluted earnings per share (EPS) improved to $2.06 for the quarter and $6.62 for the nine months, demonstrating enhanced shareholder value.
5Interest rate products showed significant growth with a 6% increase in average daily volume for the quarter and a 10% increase for the nine months, alongside a 12% rise in average rate per contract, reflecting market volatility and a transition to SOFR.
6Operating expenses increased by 6% for the quarter and 7% for the nine months, primarily due to higher compensation and benefits, technology support, and employee separation costs, but were managed effectively relative to revenue growth.
7The company maintained robust liquidity, with $2.3 billion in cash and cash equivalents and significant availability under its credit facilities.

CME GROUP INC. Quarterly Report for Q3 Ended Sep 30, 2023

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions